P32 Implementation of Early Access Reform in France and Access to Innovation: Impact in Terms of Number of Drugs, Patients Treated, and Cost
The objective of this study was to describe the impact of the reform on the number of drugs in EA, number of patients treated and cost.
Source: Value in Health - Category: International Medicine & Public Health Authors: T. Martin, C. Rioufol, N. Martelli, I. Madelaine, I. Borget Source Type: research